Your browser doesn't support javascript.
High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge.
Ujjainiya, Rajat; Tyagi, Akansha; Sardana, Viren; Naushin, Salwa; Bhatheja, Nitin; Kumar, Kartik; Barman, Joydeb; Prakash, Satyartha; Kutum, Rintu; Bhaskar, Akash Kumar; Singh, Prateek; Chaudhary, Kumardeep; Loomba, Menka; Khanna, Yukti; Walecha, Chestha; Ahmed, Rizwan; Yadav, Ashutosh; Bajaj, Archana; Malik, Gaurav; Qureshi, Sahar; Waghdhare, Swati; Siddiqui, Samreen; Trehan, Kamal Krishan; Mani, Manju; Dang, Rajiv; Das, Poonam; Dougall, Pankaj; Mahajan, Monica; Sonar, Sudipta; Jakhar, Kamini; Kumar, Reema; Tiwari, Mahima; Mani, Shailendra; Bhattacharyya, Sankar; Budhiraja, Sandeep; Agrawal, Anurag; Dash, Debasis; Jha, Sujeet; Sengupta, Shantanu.
  • Ujjainiya R; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Tyagi A; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Sardana V; Department of Clinical Research, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Naushin S; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Bhatheja N; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Kumar K; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Barman J; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Prakash S; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Kutum R; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Bhaskar AK; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Singh P; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Chaudhary K; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Loomba M; Centre of Excellence in Healthcare, IIIT-Delhi, Delhi, 110020, India.
  • Khanna Y; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Walecha C; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Ahmed R; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Yadav A; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Bajaj A; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India.
  • Malik G; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Qureshi S; Department of Clinical Research, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Waghdhare S; Department of Clinical Research, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Siddiqui S; Department of Clinical Research, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Trehan KK; Department of Clinical Research, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Mani M; Institute of Endocrinology, Diabetes, and Metabolism, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Dang R; Max Hospital Shalimar Bagh, New Delhi, 110088, India.
  • Das P; Max Hospital Shalimar Bagh, New Delhi, 110088, India.
  • Dougall P; Max Smart Super Speciality Hospital, New Delhi, 110017, India.
  • Mahajan M; Institute of Endocrinology, Diabetes, and Metabolism, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Sonar S; Institute of Endocrinology, Diabetes, and Metabolism, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Jakhar K; Max Hospital Shalimar Bagh, New Delhi, 110088, India.
  • Kumar R; Max Smart Super Speciality Hospital, New Delhi, 110017, India.
  • Tiwari M; Max Hospital, Gurgaon, Haryana, 122001, India.
  • Mani S; Institute of Laboratory Medicine & Transfusion Services, Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Bhattacharyya S; Max Super Speciality Hospital, Saket, New Delhi (A Unit of Devki Devi Foundation), New Delhi, 110017, India.
  • Budhiraja S; Max Hospital Panchsheel, New Delhi, 110017, India.
  • Agrawal A; Translational Health Science and Technology Institute, Faridabad, Haryana, 121001, India.
  • Dash D; Translational Health Science and Technology Institute, Faridabad, Haryana, 121001, India.
  • Jha S; Translational Health Science and Technology Institute, Faridabad, Haryana, 121001, India.
  • Sengupta S; Translational Health Science and Technology Institute, Faridabad, Haryana, 121001, India.
Nat Commun ; 13(1): 1726, 2022 04 01.
Article in English | MEDLINE | ID: covidwho-1773977
ABSTRACT
Immunization is expected to confer protection against infection and severe disease for vaccines while reducing risks to unimmunized populations by inhibiting transmission. Here, based on serial serological studies of an observational cohort of healthcare workers, we show that during a Severe Acute Respiratory Syndrome -Coronavirus 2 Delta-variant outbreak in Delhi, 25.3% (95% Confidence Interval 16.9-35.2) of previously uninfected, ChAdOx1-nCoV19 double vaccinated, healthcare workers were infected within less than two months, based on serology. Induction of anti-spike response was similar between groups with breakthrough infection (541 U/ml, Inter Quartile Range 374) and without (342 U/ml, Inter Quartile Range 497), as was the induction of neutralization activity to wildtype. This was not vaccine failure since vaccine effectiveness estimate based on infection rates in an unvaccinated cohort were about 70% and most infections were asymptomatic. We find that while ChAdOx1-nCoV19 vaccination remains effective in preventing severe infections, it is unlikely to be completely able to block transmission and provide herd immunity.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-29404-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-29404-3